Get the Stockscreener App
21.43
2.93%
0.61
After Hours:
21.43
Fulgent Genetics Inc stock is traded at $21.43, with a volume of 294.63K.
It is up +2.93% in the last 24 hours and up +13.87% over the past month.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
See More
Previous Close:
$20.82
Open:
$21.02
24h Volume:
294.63K
Relative Volume:
0.63
Market Cap:
$630.79M
Revenue:
$290.71M
Net Income/Loss:
$-163.43M
P/E Ratio:
-3.9106
EPS:
-5.48
Net Cash Flow:
$11.70M
1W Performance:
+3.43%
1M Performance:
+13.87%
6M Performance:
+6.67%
1Y Performance:
+3.38%
1-Day Range:
$20.96
$21.56
1-Week Range:
$20.00
$21.87
52-Week Range:
$14.76
$25.11
Fulgent Genetics Inc Stock (FLGT) Company Profile
Name
Fulgent Genetics Inc
Sector
Industry
Phone
626-350-0537
Address
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
21.43 | 630.79M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
401.90 | 152.06B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
196.02 | 135.91B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
524.91 | 41.29B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
115.80 | 31.79B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
152.32 | 24.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-08-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-18-22 | Initiated | Raymond James | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Feb-04-22 | Resumed | Piper Sandler | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Underperform |
| Jan-08-21 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-20-20 | Initiated | Oppenheimer | Outperform |
| May-29-20 | Initiated | BTIG Research | Buy |
| Nov-05-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Mar-01-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Nov-07-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Fulgent Genetics Inc Stock (FLGT) Latest News
Squarepoint Ops LLC Acquires 26,659 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent ... - Bluefield Daily Telegraph
Nuveen Asset Management LLC Has $1.04 Million Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Investors to Connect - ACCESS Newswire
Nuveen Asset Management LLC Has $1.04 Million Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Bank of America Corp DE Sells 57,224 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Two Sigma Advisers LP Buys 19,000 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics Executives Sell Shares to Satisfy Tax Obligations - TradingView
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Bragar Eagel & Squire, P.C. Is Investigating EchoStar, Semler, ADTRAN, and Fulgent and ... - Eagle-Tribune
Bragar Eagel & Squire, P.C. Is Investigating EchoStar, - GlobeNewswire
Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Fulgent Genetics, Inc. (NASDAQ:FLGT) is definitely on the radar of institutional investors who own 48% of the company - Yahoo Finance
Fulgent Genetics, Inc. (NASDAQ:FLGT) COO Sells $38,471.42 in Stock - MarketBeat
LA500 2025: Ming Hsieh - Los Angeles Business Journal
Insider Selling: Fulgent Genetics, Inc. (NASDAQ:FLGT) Insider Sells 1,039 Shares of Stock - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.FLGT - PR Newswire
Quantinno Capital Management LP Purchases New Shares in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Tempus AI Inc. (NASDAQ: TEM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Stockholders to Connect - ACCESS Newswire
Northern Trust Corp Has $4.16 Million Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces - GlobeNewswire
Point72 Asset Management L.P. Has $2.65 Million Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $987,000 Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Purchased by Millennium Management LLC - MarketBeat
D. E. Shaw & Co. Inc. Purchases 73,843 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
FLGT Investors Have Opportunity to Join Fulgent Genetics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
Fulgent genetics targets $310M core revenue in 2025 with strong growth in diagnostics and pathology - MSN
Ameriprise Financial Inc. Grows Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on ... - Bluefield Daily Telegraph
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Deutsche Bank AG Has $2.43 Million Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics Inc (FLGT) Stock Price Down 3.03% on May 21 - GuruFocus
Balyasny Asset Management L.P. Invests $486,000 in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics Inc (FLGT) Shares Up 3.66% on May 19 - GuruFocus
Cubist Systematic Strategies LLC Grows Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc - marketscreener.com
Fulgent Genetics holds annual stockholders meeting By Investing.com - Investing.com Canada
Fulgent Genetics Holds Annual Stockholders Meeting - TipRanks
Fulgent Genetics holds annual stockholders meeting - Investing.com
Fulgent Genetics Inc Stock (FLGT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Fulgent Genetics Inc Stock (FLGT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Xie Jian | President and COO |
Jun 02 '25 |
Sale |
20.29 |
1,135 |
23,030 |
371,496 |
0.40%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):